The balance between the adhesion of cancer cells to extracellular matrix and their migratory potential, as well as their proteolytic activity, are important parameters that determine cancer cells invasiveness and metastasis. Since thrombin has been implicated in cancer progression, we studied the role(s) of thrombin-activated receptors in the adhesion process. We stably knocked down proteinase-activated receptors (PARs) -1, or -3 in human pancreatic adenocarcinoma PANC-1 cells. PANC-1 cells exhibit rapid adhesion to cell culture treated plastic and much faster kinetics of adhesion to Matrigel coated surface. Knockdown of PAR-1 had no effect on cells' adhesiveness, while PAR-3 knockdowns (KDs) exhibited much faster adhesion kinetics. PAR-3 KDs also exhibited slower in vitro wound closure than vector-control and PAR-1 KD cells. To study the molecular mechanism(s) of PAR-3 KD cells' enhanced rate of adhesion, we assayed the expression of the molecules that mediate cell-surface and cell-cell adhesion. ITGαv, as well as ITGα6 and ITGα10 mRNAs, were greatly enriched (>40-fold) in a rapidly-adhering sub-population of PAR-3 KD cells. The whole population of both PAR-1 and -3 KDs exhibited enhanced expression of a number of integrins (ITGs) mRNAs. However, ITGαv mRNA and protein expression was increased in PAR-3 KD and markedly decreased in PAR-1 KD. PAR-3 KD cells also expressed more E-cadherin mRNA and protein. The enhanced adhesion kinetics of PAR-3 KDs was almost fully inhibited by calcium chelation, or by a HAV-motive decapeptide that affects E-cadherin intermolecular interactions. We propose that the enhanced rate of adhesion of PAR-3 KDs results from enhanced expression of E-cadherin, leading to a greater adhesion of free-floating cells to cells rapidly bound to the surface via their integrins, and particularly ITGαv.
References
[1]
Friedl P, Alexander S (2011) Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147: 992–1009. doi: 10.1016/j.cell.2011.11.016
[2]
Gritsenko PG, Ilina O, Friedl P (2012) Interstitial guidance of cancer invasion. J Pathol 226: 185–199. doi: 10.1002/path.3031
[3]
Perlikos F, Harrington KJ, Syrigos KN (2013) Key molecular mechanisms in lung cancer invasion and metastasis: a comprehensive review. Crit Rev Oncol Hematol 87: 1–11. doi: 10.1016/j.critrevonc.2012.12.007
Iovanna J, Mallmann MC, Goncalves A, Turrini O, Dagorn JC (2012) Current knowledge on pancreatic cancer. Front Oncol 2: 6. doi: 10.3389/fonc.2012.00006
Elste AP, Petersen I (2010) Expression of proteinase-activated receptor 1-4 (PAR 1-4) in human cancer. J Mol Histol 41: 89–99. doi: 10.1007/s10735-010-9274-6
[8]
Franchini M, Mannucci PM (2012) Thrombin and cancer: from molecular basis to therapeutic implications. Semin Thromb Hemost 38: 95–101. doi: 10.1055/s-0031-1300955
[9]
Segal L, Katz LS, Lupu-Meiri M, Shapira H, Sandbank J, et al. (2013) Proteinase-activated receptors differentially modulate in vitro invasion of human pancreatic adenocarcinoma PANC-1 cells in correlation with changes in the expression of CDC42 protein. Pancreas 43: 103–108. doi: 10.1097/mpa.0b013e31829f0b81
[10]
Zaidel-Bar R, Geiger B (2010) The switchable integrin adhesome. J Cell Sci 123: 1385–1388. doi: 10.1242/jcs.066183
[11]
van Roy F, Berx G (2008) The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 65: 3756–3788. doi: 10.1007/s00018-008-8281-1
[12]
Deshet N, Lupu-Meiri M, Espinoza I, Fili O, Shapira Y, et al. (2008) Plasminogen-induced aggregation of PANC-1 cells requires conversion to plasmin and is inhibited by endogenous plasminogen activator inhibitor-1. J Cell Physiol 216: 632–639. doi: 10.1002/jcp.21441
[13]
Watt FM (2002) Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J 21: 3919–3926. doi: 10.1093/emboj/cdf399
[14]
Kobayashi N, Ikesue A, Majumdar S, Siahaan TJ (2006) Inhibition of e-cadherin-mediated homotypic adhesion of Caco-2 cells: a novel evaluation assay for peptide activities in modulating cell-cell adhesion. J Pharmacol Exp Ther 317: 309–316. doi: 10.1124/jpet.105.097535
[15]
Fujimoto D, Hirono Y, Goi T, Katayama K, Matsukawa S, et al. (2010) The activation of Proteinase-Activated Receptor-1 (PAR1) mediates gastric cancer cell proliferation and invasion. BMC Cancer 10: 443. doi: 10.1186/1471-2407-10-443
[16]
Kaufmann R, Junker U, Nuske K, Westermann M, Henklein P, et al. (2002) PAR-1- and PAR-3-type thrombin receptor expression in primary cultures of human renal cell carcinoma cells. Int J Oncol 20: 177–180. doi: 10.3892/ijo.20.1.177
[17]
Kaushal V, Kohli M, Dennis RA, Siegel ER, Chiles WW, et al. (2006) Thrombin receptor expression is upregulated in prostate cancer. Prostate 66: 273–282. doi: 10.1002/pros.20326
[18]
Bretschneider E, Spanbroek R, Lotzer K, Habenicht AJ, Schror K (2003) Evidence for functionally active protease-activated receptor-3 (PAR-3) in human vascular smooth muscle cells. Thromb Haemost 90: 704–709. doi: 10.1160/th03-04-0203
[19]
McLaughlin JN, Patterson MM, Malik AB (2007) Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization. Proc Natl Acad Sci U S A 104: 5662–5667. doi: 10.1073/pnas.0700763104
[20]
Canel M, Serrels A, Frame MC, Brunton VG E-cadherin-integrin crosstalk in cancer invasion and metastasis. J Cell Sci 126: 393–401. doi: 10.1242/jcs.100115